0001209191-19-018103.txt : 20190308 0001209191-19-018103.hdr.sgml : 20190308 20190308163021 ACCESSION NUMBER: 0001209191-19-018103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190220 FILED AS OF DATE: 20190308 DATE AS OF CHANGE: 20190308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYNJELSEN SEAN CENTRAL INDEX KEY: 0001669976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 19669494 MAIL ADDRESS: STREET 1: C/O ETON PHARMACEUTICALS, INC. STREET 2: 21925 W FIELD PKWY #235 CITY: DEER PARK STATE: IL ZIP: 60010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7208 BUSINESS PHONE: (847) 787-7361 MAIL ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7208 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-20 0 0001710340 Eton Pharmaceuticals, Inc. ETON 0001669976 BRYNJELSEN SEAN 21925 W FIELD PKWY #235 DEER PARK IL 60010 1 1 0 0 President & CEO Stock option (right to buy) 7.31 2019-02-20 4 A 0 250000 0.00 A 2029-02-19 Common Stock 250000 250000 D The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2021. /s/ W. Wilson Troutman, Attorney-in-fact 2019-03-08